Frech, Tracy M
United States Department of Veterans Affairs · VA Tennessee Valley Healthcare System · Vanderbilt University Medical Center
4 papers on CoChatORCID 0000-0002-5472-3840
Most cited papers
- Verified
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
Khanna, D., Denton, C. P., Jahreis, A., van Laar, J. M., Frech, T. M., Anderson, M. E., Baron, M., Chung, L., Fierlbeck, G., Lakshminarayanan, S., et al. (2016) · The Lancet
Systemic Sclerosis and Related DiseasesRheumatoid Arthritis Research and Therapies
Cited by 683
- Verified
Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)
Khanna, D., Denton, C. P., Lin, C. J. F., van Laar, J. M., Frech, T. M., Anderson, M. E., Baron, M., Chung, L., Fierlbeck, G., Lakshminarayanan, S., et al. (2018) · Annals of the Rheumatic Diseases
Systemic Sclerosis and Related DiseasesConnective tissue disorders research
Cited by 265
- Verified
Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile
Skaug, B., Khanna, D., Swindell, W. R., Hinchcliff, M. E., Frech, T. M., Steen, V. D., Hant, F. N., Gordon, J. K., Shah, A. A., Zhu, L., et al. (2020) · Annals of the Rheumatic Diseases
Systemic Sclerosis and Related DiseasesDupuytren's Contracture and Treatments
Cited by 179
- Verified
Expanding personalized, data-driven dermatology: leveraging digital health technology and machine learning to improve patient outcomes
Wongvibulsin, S., Frech, T. M., Chren, M.-M., & Tkaczyk, E. R. (2022) · JID Innovations
Artificial Intelligence in Healthcare and EducationDermatology and Skin Diseases
Cited by 29
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free